Governor Baker’s health care bill will not reduce out of pocket costs for patients as it fails to recognize the role insurers play in setting the prices for prescription drugs. In fact, it would have countless unintended consequences for patients with unmet medical needs.  With little time left in this legislative session and other healthcare reform proposals on the table, we hope legislators focus on more direct solutions, such as mandating insurers share drug rebates directly with patients to drive down costs without jeopardizing new drugs reaching patients.

See all MassBio News